Katie Couric announced Wednesday that she was diagnosed with Stage 1 breast cancer in June after missing her annual mammogram. TODAY’s Sheinelle Jones reports on the message Couric released encouraging people to get screened.
The American Association for Cancer Research (AACR) honored numerous esteemed individuals and organizations during the AACR 115th Anniversary Event in Washington, D.C., on Wednesday, September 21, for their outstanding achievements in advancing cancer research. More than 250 guests from the cancer research field attended the event hosted by Margaret Foti, PhD, MD (hc), Chief Executive Officer of the AACR.
Stand Up To Cancer (SU2C) brought together local health organization Providence St. John’s/Santa Monica, UCLA Health, and community organizations in South and East Lost Angeles to proactively address ongoing disparities in screening and treatment of colorectal cancers, successfully increasing screening rates to 80% within the SU2C Zones.
Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.
Now through Sept. 30, 2022, you can earn 25 or 50 AAdvantage miles per dollar when donating between $25 and $10,000 to Stand Up to Cancer.
The actress opens up about her new SU2C partnership, preparing for her second child and what she’s looking for in her next gig: “Clearly, nothing will ever hold the same place in my heart as [‘This Is Us’].”
Rusty Robertson, co-founder of Stand Up To Cancer, and Dr. Alexander Lloyd Blake, music director for LACHSA, discuss performance during SU2C placard moment at the 2022 MLB All-Star game.
At Eyemart Express, for every pair of Stand Up To Cancer (SU2C) glasses purchased from July 18 through Aug. 27, $5 will be donated to the cause, aiming to make all cancer patients long-term survivors.
Given the numbers of diversity in clinical trials, regulators and sponsors are trying to broaden the recruitment of people from different racial and ethnic groups. But one thing is missing: a clear explanation of why this is important.
Founded 80 years ago by Hollywood’s biggest names (Goldwyn! Bogart! Crawford!), The Hollywood Reporter’s Philanthropic Organization of the Year empowers celebrity activists to tackle the world’s most daunting challenges.
